New pharmaceuticals in inflammatory bowel disease

7Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

This paper complements the previously published Guidelines of the Working Group of the Polish Society of Gastroenterology and former National Consultant in Gastroenterology regarding the management of patients with Crohn's disease and ulcerative colitis. Attention was focused on the new pharmaceutical recently registered for inflammatory bowel disease treatment.

Cite

CITATION STYLE

APA

Łodyga, M., Eder, P., Bartnik, W., Gonciarz, M., Kłopocka, M., Linke, K., … Rydzewska, G. (2015). New pharmaceuticals in inflammatory bowel disease. Przeglad Gastroenterologiczny, 10(2), 57–60. https://doi.org/10.5114/pg.2015.52702

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free